News and Press Releases
Press releases
Theralase Release’s Q322 Interim Financial Statements
Toronto, Ontario – November 29, 2022, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinica...
0Theralase® Grants Stock Options
Toronto, Ontario – November 21, 2022, Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinic...
0Theralase ® Closes Private Placement Equity Financing
Toronto, Ontario – November 17, 2022, Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinic...
0Theralase ® Commences $CAN 2.5 M Follow-On Private Placement Equity Financing
Not for distribution to U.S. news wire services or dissemination in the United States. Toronto, Ontario – October 3, 2022, Theralase® Technologi...
0Theralase ® Announces Warrant Extension
Toronto, Ontario – September 29, 2022, Theralase® Technologies Inc. (“Theralase” or “Company“) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
0Theralase ® Closes $2.5M Private Placement Equity Financing
Toronto, Ontario – September 22, 2022, Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clin...
0Theralase Release’s Q222 Interim Financial Statements
Toronto, Ontario – August 29, 2022, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical ...
0Theralase Expands Intellectual Property Portfolio
Toronto, Ontario – June 28, 2022, Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical ...
0Theralase® Research – One of the Top 10 Most Downloaded Papers
Toronto, Ontario – June 24, 2022, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical sta...
0Theralase® Phase Ib NMIBC Clinical Study Published
Toronto, Ontario – June 21, 2022, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical st...
0in the news
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.
